Summary
There are numerous clinical and experimental similarities between amine induced stereotyped behavior and tardive dyskinesia. The results presented here show that chronic pretreatment of guinea pigs with chlorpromazine produces a persistent reduction in the amounts of amphetamine or apomorphine needed to induce stereotyped behavior. It is suggested that chlorpromazine pretreatment may alter the sensitivity of the striatal dopaminergic receptors to dopamine. The alteration in receptor site responsiveness produced by prolonged chlorpromazine pretreatment may be analogous to the neuroleptic induced tardive dyskinesias. The same dopaminergic mechanism may underlie both the amine stereotyped behavior seen in animals and tardive dyskinesias in man, while lingual-facial-buccal dyskinesias may be the human equivalent of the stereotypies seen in animals when the dopaminergic response in the striatum is increased.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnfred, T., andA. Randrup: Cholinergic mechanism in brain inhibiting amphetamine induced stereotyped behavior. Acta Pharmacol. Tox.26., 384–394 (1968).
Birkmayer, W.: The α-methyl-p-tyrosine effect in extrapyramidal disorders. Wien. Klin. Wschr.81, 10 (1969).
Burkard, W. P., K. F. Gey, andA. Pletscher: Activation of tyrosine hydroxylation in rat brainin vivo by chlorpromazine. Nature213, 732 (1967).
Carlsson, A., andM. Lindqvist: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Tox.20, 140–144 (1963).
Cools, A. R., andJ. M. Van Rossum: Caudal dopamine and stereotyped behavior of cats. Arch. Int. Pharmacodyn. Ther.187, 163–173 (1970).
Corrodi, H., andL. C. F. Hanson: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (Berlin)10, 116–125 (1966).
Crane, G. E.: Tardive dyskinesias in patients treated with major neuroleptics: A review of the literature. Amer. J. Psychiat.124, 8 (1968).
Da Prada, M., andA. Pletscher: Acceleration of cerebral dopamine turnover by chlorpromazine. Experientia22, 465 (1966).
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharm.10, 316–323 (1967).
Ernst, A. M.: The role of biogenic amines in the extrapyramidal system. Acta Physiol. Pharmacol. Neurol.15, 141–154 (1969).
Ernst, A. M., andP. G. Smelik: Site of action of dopamine and apomorphine on compulsive gnawing behavior in rats. Experientia (Basel)22, 837–838 (1966).
Faurbye, A.: The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases. Comprehens. Psychiat.11, 205–224 (1970).
Faurbye, A., P. J. Rasch, P. Bender Peterson, G. Porandborg, andH. Pakkenberg: Neurologic symptoms in the pharmacology of psychoses. Acta Psychiat. Scand.40, 10–26 (1964).
Fog, R., andH. Pakkenberg: Behavioral effects of dopamine and p-hydroxyamphetamime injected into corpus striatum of rats. Exp. Neurol.31, 75–86 (1971).
Fog, R. L., A. Randrup, andH. Pakkenberg: Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behavior. Psychopharmacologic (Berlin)11, 179–183 (1967).
Fog, R. L., A. Randrup, andH. Pakkenberg: Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats. Psychopharmacologia (Berlin)12, 428–432 (1968).
Gey, K. F., andA. Pletscher: Influence of chlorpromazine and chlorprothixene on the cerebral metabolism of 5-hydroxytryptamine, norepinephrine and dopamine. J. Pharmacol. Exp. Ther.133, 18–24 (1961).
Guldberg, H. C., andC. M. Yates: Effects of chlorpromazine on the metabolism of catecholamines in dog brain. Brit. J. Pharmacol.36, 535–548 (1969).
Hanson, L. C. F.: Evidence that the central action of amphetamine is mediated via catecholamines. Psychopharm.9, 78–90 (1966).
Klawans, H. L., Jr.: A pharmacologie analysis of Huntington's chorea. Europ. Neurol.4, 148–163 (1970).
Klawans, H. L., Jr., M. M. Ilahi, andD. Shenker: Theoretical implications of the use of L-dopa in parkinsonism. Acta Neurol. Scand.46, 409–441 (1970).
Klawans, H. L. Jr., andR. McKendall: Observations on the effect of L-dopa on tardive lingual-facial-buccal dyskinesia. J. Neurol. Sci.14, 189–192 (1971).
Munkvad, I., H. Pakkenberg, andA. Randrup: Aminergic systems in basal ganglia associated with stereotyped hyperactive behavior and catalepsy. Brain Behav. Evol.1, 89–100 (1968).
Nyback, H., A. Borzeck, andG. Sedvall: Accumulation and disappearance of catecholamines formed from tyrosine-14-C in mouse brain; effect of some psychotropic drugs. Europ. J. Pharmacol.14, 395–403 (1968).
Nyback, H., andG. Sedvall: Regional accumulation of catecholamines formed from tyrosine-14-C in rat brain; effect of chlorpromazine. Europ. J. Pharmacol.5, 245–252 (1969).
Nyback, H., G. Sedvall, andI. J. Kopen: Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine. Life Sci.6, 2307 (1967).
Ohye, C., R. Bouchard, R. Boucher, andL. Poirier: Spontaneous activity of the putamen after chronic interruption of the dopaminergic pathway; effect of L-dopa. J. Pharmacol. Exp. Ther.175, 700–708 (1970).
Paulson, G. W.: “Permanent” or complex dyskinesias in the aged. Geriatrics23, 105–110 (1968).
Randrup, A., andI. Munkvad: Role of catecholamines in the amphetamine excitatory response. Nature (London)211, 540 (1966).
Randrup, A., andI. Munkvad: Stereotyped activities produced by amphetamine in several animal species and man. Psychopharm. (Berlin)11, 300–310 (1967).
Scheel-Kruger, J.: Central effects of anticholinergic drugs measured by the apomorphine gnawing test in mice. Acta Pharmacol. Tox.28, 1–16 (1970).
Scheel-Kruger, J.: Comparative studies of various amphetamine analogs demonstrating different interactions with the metabolism of the catecholamines in the brain. Europ. J. Pharmacol.19, 47–59 (1971).
Spector, S., A. Sjoerdsma, andS. Udenfriend: Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol.147, 86–95 (1965).
Van Rossum, J. M.: The significance of dopamine-receptor blockade for the action of neuroleptic drugs. Fifth Int. Cong. Neuropsychopharm., 321–329 (1966).
Weissmann, A., K. B. Koe, andS. S. Tenen: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. Exp. Ther.151, 339–352 (1966).
Author information
Authors and Affiliations
Additional information
Dr.Rubovits is a resident in the Department of Psychiatry, University of Maryland Hospital, Baltimore, Maryland.
Rights and permissions
About this article
Cite this article
Klawans, H.L., Rubovits, R. An experimental model of tardive dyskinesia. J. Neural Transmission 33, 235–246 (1972). https://doi.org/10.1007/BF01245320
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01245320